Abstract
The use of distal embolic protection devices (EPD) in saphenous vein graft percutaneous interventions (SVG-PCI) has been associated with a decrease in adverse events. Currently, there are limited data regarding the percentage of SVG lesions that are suitable for EPD deployment. We retrospectively reviewed 131 SVG-PCI procedures occurring over 18 months for suitability for EPD deployment, utilizing previously published suitability criteria. We found that 49 of cases were suitable for EPD use, which is similar to results from other studies. Given the data supporting the use of EPD use in SVG-PCI, we feel that these findings should motivate interventional operators to establish benchmark standards for employing EPDs to improve the care of patients undergoing SVG-PCI.
Original language | English (US) |
---|---|
Pages (from-to) | 568-570 |
Number of pages | 3 |
Journal | Journal of Invasive Cardiology |
Volume | 20 |
Issue number | 11 |
State | Published - Nov 2008 |
Fingerprint
Keywords
- Distal embolic protection devices
- SVG-PCI
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
- Radiology Nuclear Medicine and imaging
- Medicine(all)
Cite this
Suitability of saphenous vein graft lesions for the use of distal embolic protection devices. / Mehta, Sameer K.; Stolker, Joshua M.; Frutkin, Andrew D.; Marso, Steven P.
In: Journal of Invasive Cardiology, Vol. 20, No. 11, 11.2008, p. 568-570.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Suitability of saphenous vein graft lesions for the use of distal embolic protection devices
AU - Mehta, Sameer K.
AU - Stolker, Joshua M.
AU - Frutkin, Andrew D.
AU - Marso, Steven P.
PY - 2008/11
Y1 - 2008/11
N2 - The use of distal embolic protection devices (EPD) in saphenous vein graft percutaneous interventions (SVG-PCI) has been associated with a decrease in adverse events. Currently, there are limited data regarding the percentage of SVG lesions that are suitable for EPD deployment. We retrospectively reviewed 131 SVG-PCI procedures occurring over 18 months for suitability for EPD deployment, utilizing previously published suitability criteria. We found that 49 of cases were suitable for EPD use, which is similar to results from other studies. Given the data supporting the use of EPD use in SVG-PCI, we feel that these findings should motivate interventional operators to establish benchmark standards for employing EPDs to improve the care of patients undergoing SVG-PCI.
AB - The use of distal embolic protection devices (EPD) in saphenous vein graft percutaneous interventions (SVG-PCI) has been associated with a decrease in adverse events. Currently, there are limited data regarding the percentage of SVG lesions that are suitable for EPD deployment. We retrospectively reviewed 131 SVG-PCI procedures occurring over 18 months for suitability for EPD deployment, utilizing previously published suitability criteria. We found that 49 of cases were suitable for EPD use, which is similar to results from other studies. Given the data supporting the use of EPD use in SVG-PCI, we feel that these findings should motivate interventional operators to establish benchmark standards for employing EPDs to improve the care of patients undergoing SVG-PCI.
KW - Distal embolic protection devices
KW - SVG-PCI
UR - http://www.scopus.com/inward/record.url?scp=62449238407&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=62449238407&partnerID=8YFLogxK
M3 - Article
C2 - 18987394
AN - SCOPUS:62449238407
VL - 20
SP - 568
EP - 570
JO - Journal of Invasive Cardiology
JF - Journal of Invasive Cardiology
SN - 1042-3931
IS - 11
ER -